CXCR4 and central nervous system cancer: Glioma cells overexpressing CXCR4 were treated with increasing doses of the compound, resulting in the inhibition of cell growth in a dose-dependent manner, especially in the U87 cell line, and in increase in apoptosis without apparent toxicity.